FDA Inspection 824233 — Regenerative Biologics, Inc.

Regenerative Biologics, Inc. — FEI 3003567064

The FDA completed an inspection of Regenerative Biologics, Inc. on March 29, 2013 in Tallahassee, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 29, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Tallahassee, FL (United States)